We are live on ! Find out more
BIIB icon

Biogen
BIIB

943 hedge funds and large institutions have $29.9B invested in Biogen in 2024 Q2 according to their latest regulatory filings, with 101 funds opening new positions, 322 increasing their positions, 337 reducing their positions, and 97 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding in top 10

Funds holding in top 10: 9 → 12 (+3)

7% more capital invested

Capital invested by funds: $28B → $29.9B (+$1.92B)

4% more first-time investments, than exits

New positions opened: 101 | Existing positions closed: 97

0.65% less ownership

Funds ownership: 89.26% → 88.6% (-0.65%)

4% less repeat investments, than reductions

Existing positions increased: 322 | Existing positions reduced: 337

10% less call options, than puts

Call options by funds: $318M | Put options by funds: $353M

1% less funds holding

Funds holding: 954 → 943 (-11)

Holders
943
Holders Change
-11
Holders Change %
-1.15%
% of All Funds
13.62%
Holding in Top 10
12
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+33.33%
% of All Funds
0.17%
New
101
Increased
322
Reduced
337
Closed
97
Calls
$318M
Puts
$353M
Net Calls
-$34.4M
Net Calls Change
-$35M

Top Buyers

Rank Fund Capital Flow
1
Ameriprise
Ameriprise
Minnesota
+$142M
2
Norges Bank
Norges Bank
Norway
+$121M
3
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
+$111M
4
Goldman Sachs
Goldman Sachs
New York
+$92.7M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$91.7M

Top Sellers

Rank Fund Capital Flow
1
VanEck Associates
VanEck Associates
New York
-$177M
2
Deutsche Bank
Deutsche Bank
Germany
-$87.8M
3
CCM
Camber Capital Management
Massachusetts
-$86.3M
4
Invesco
Invesco
Georgia
-$82.3M
5
Pictet Asset Management
Pictet Asset Management
Switzerland
-$73.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
MWA
901
MFA Wealth Advisors
Pennsylvania
$3.48K +$3.26K +15 New
DPW
902
DiNuzzo Private Wealth
Pennsylvania
$3.25K +$217 +1 +8%
KA
903
Kozak & Associates
Colorado
$3.15K – – –
HCM
904
Hollencrest Capital Management
California
$3.01K – – –
OSNBOA
905
Old Second National Bank of Aurora
Illinois
$3.01K +$2.83K +13 New
PCM
906
Penserra Capital Management
California
$3K – – –
FMP
907
Financial Management Professionals
Texas
$3K +$1.09K +5 +83%
AW
908
Avion Wealth
Texas
$3K +$3.04K +14 +700%
FCAS
909
First Command Advisory Services
Texas
$2.78K +$2.61K +12 New
FFO
910
Fortitude Family Office
Arizona
$2.78K +$2.61K +12 New
RWM
911
Ruedi Wealth Management
Illinois
$2.78K +$2.61K +12 New
PCMC
912
Planning Capital Management Corporation
Pennsylvania
$2.55K – – –
BAM
913
Byrne Asset Management
New Jersey
$2.29K – – –
SIS
914
Strategic Investment Solutions
Illinois
$2.13K +$2.17K +10 New
SIC
915
SJS Investment Consulting
Ohio
$2.09K -$1.52K -7 -44%
AP
916
Aspect Partners
Virginia
$2.09K – – –
QL
917
Quarry LP
New York
$2.09K +$1.96K +9 New
VWA
918
Valued Wealth Advisors
Utah
$1.85K -$1.52K -7 -47%
APC
919
Aspire Private Capital
North Carolina
$1.85K – – –
AP
920
Atwood & Palmer
Missouri
$1.74K – – –
CIA
921
Cape Investment Advisory
Georgia
$1.62K – – –
PPC
922
Park Place Capital
Alabama
$1.62K – – –
TFM
923
TFC Financial Management
Massachusetts
$1.62K +$652 +3 +75%
RFG
924
RFP Financial Group
Georgia
$1.39K -$869 -4 -40%
FG
925
Fairman Group
Pennsylvania
$1.39K – – –
35 36
37
38 39

BIIB Hedge Fund Activity: Q2 2024 in Review

943 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Biogen (BIIB) for Q2 2024, worth a combined $29.9B — up 6.9% from $28B a quarter earlier.

Buyers outnumbered sellers: 101 funds opened new BIIB positions and 97 closed out — a net gain of 4 holders — while 322 added to existing stakes and 337 trimmed.

The largest buyer was Ameriprise, adding an estimated $142M. The largest seller was VanEck Associates, cutting an estimated $177M.

  • 943 institutional investors held Biogen (BIIB) as of Q2 2024, down from 954 in Q1 2024.
  • Funds reported $29.9B of Biogen stock for Q2 2024, up 6.9% quarter-over-quarter.
  • 101 funds opened new Biogen positions in Q2 2024 and 97 closed out, a net change of +4 holders.
  • The largest Biogen buyer in Q2 2024 was Ameriprise, an estimated $142M added.
  • The largest Biogen seller in Q2 2024 was VanEck Associates, an estimated $177M sold.

Based on aggregated 13F filings for Q2 2024.